Neisseriaceae Infections - 12 Studies Found Terminated : Hormonal Contraception and Risk of Chlamydia and Gonorrhea : Chlamydia Infection Neisseriaceae Infection : 2004-09-16 : Drug: Depo Medroxyprogesterone acetate Dru Recruiting : Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination : Infections, Meningococcal : 2016-12-06 : Biological: Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate Vaccine (Menveo) Recruiting : Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents : Infections, Meningococcal : 2016-10-25 : Biological: Meningococcal ABCWY Vaccine Completed : Combined Study - Phase 3b MenB Long Term Persistence in Adolescents : Infections, Meningococcal : 2015-05-06 : Biological: Meningococcal Group B (rDNA Component adsorbed) (rMenB+OMV NZ) In Group A, intramuscular Boo Active, not recruiting : Investigating Meningococcal Vaccines in Adults : Meningococcal Vaccines Meningococcal Infections Neisseria : 2015-03-20 : Biological: 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics 4CMenB vaccine (Bexsero - Novarti Recruiting : Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry : Meningococcal Disease Pregnancy : 2014-08-20 : Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This pregnancy registry is strictly obs Completed : Trial to Assess Immunogenicity and Safety of Novartis Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents : Meningococcal Disease : 2014-08-06 : Biological: rMenB+OMV Other: Placebo Completed : Safety and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan. : Meningococcal Disease : 2014-06-05 : Biological: Bexsero® Four Completed : Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants : Infections, Meningococcal : 2014-02-14 : Biological: Meningococcal group B Vaccine, rMenB+OMV NZ Completed : Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180) : Meningococcal Disease : 2013-11-15 : Biological: MenABCWY+OMV Vacci Next >>>
